Longeveron Inc. (LGVN)
NASDAQ: LGVN · Real-Time Price · USD
0.615
-0.018 (-2.80%)
At close: Dec 5, 2025, 4:00 PM EST
0.611
-0.004 (-0.72%)
After-hours: Dec 5, 2025, 7:53 PM EST
Longeveron Market Cap
Longeveron has a market cap or net worth of $13.12 million as of December 5, 2025. Its market cap has decreased by -54.18% in one year.
Market Cap
13.12M
Enterprise Value
4.86M
1-Year Change
-54.18%
Ranking
Category
Stock Price
$0.62
Market Cap Chart
Since the IPO on February 12, 2021, Longeveron's market cap has decreased from $172.48M to $13.12M, a decrease of -92.39%. That is a compound annual growth rate of -41.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 13.50M | -47.42% |
| Dec 31, 2024 | 25.67M | -24.83% |
| Dec 29, 2023 | 34.15M | -49.55% |
| Dec 30, 2022 | 67.68M | -72.36% |
| Dec 31, 2021 | 244.90M | 41.99% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |